Cardiometabolic Health Congress | Agenda | CME Conference Schedule, Symposia, Keynote Session, Presentations

Home

•

Site Map

•

Useful Links

October 20-23, 2010 · Sheraton Boston Hotel · Boston, MA

Join Our Mailing List

2010 Congress Details

2009 Congress Details

2008 Congress Details

2007 Congress Details

2006 Congress Details

2009 Online CME Activity

Useful Links

Recommend This Site

Download the
2010 Program Brochure

2010 Preliminary Program Agenda

Wednesday Thursday Friday Saturday

The 2010 Cardiometabolic Health Congress Agenda will be updated as the program is developed.
Join our mailing list to receive updates.

Pre-conference, Wednesday, October 20, 2010

3:00pm – 5:00pm

Meet-the-Expert
Challenging Case Study Session

Preregistration Required!
Space limited to 150 participants. Reservations are taken on a first-come, first-serve basis, so please register early to take advantage of this exclusive opportunity. Once registered, you will receive details on how to submit and, if selected, present your case study for discussion during the 2010 CMHC.

George Bakris, MD
Christie Ballantyne, MD
John Buse, MD
Christopher Cannon, MD
Robert Eckel, MD
Richard Nesto, MD
Jay Skyler, MD

6:00pm – 8:00pm

Dinner Symposium
Cardiometabolic Risk Reduction in Patients with T2DM: Expert Recommendations for Anti-hyperglycemic Therapy Selection to Achieve Optimal Outcomes
Supported by an educational grant from Amylin/Lilly

John Buse, MD
Anne Peters, MD
Robert Ratner, MD
Carol Wysham, MD

Thursday, October 21, 2010
6:30am – 8:00am	Breakfast Symposia A Overcoming Today's Top Challenges in Ischemic Heart Disease: Clinical Controversies and Evidence-Based Solutions for Optimizing Patient Care Supported by an independent educational grant from Gilead Sciences Medical Affairs	C. Noel Bairey Merz, MD Christopher Cannon, MD Peter Stone, MD Robert Wilensky, MD
6:30am – 8:00am	Breakfast Activity B 6:30am - 7:00am Complimentary Breakfast Provided by the CMHC 7:00am - 8:00am Evidence and Consensus on T2DM Patient Management: Early and Individualized Treatment to Goal (No CME credits will be offered)	James Gavin III, MD, PhD
8:00am – 8:10am	Opening Remarks	Christie Ballantyne, MD
8:10am – 8:50am	Keynote Presentation The Science Behind Inflammation and Cardiometabolic Risk	Peter Libby, MD
8:50am - 9:30am	Keynote Presentation Inflammation and Cardiometabolic Risk: Integrating the Science into Clinical Practice	Paul Ridker, MD
9:30am – 10:15am	Morning Break/Exhibit Hall
10:15am - 11:30pm	The Most Sought After CMHC Session! Late-Breaking Clinical Trials: Expert Insights on How the Latest Data Impacts Your Clinical Practice	moderator: Richard Nesto, MD panelists: Christie Ballantyne, MD Christopher Cannon, MD Robert Eckel, MD Keith Ferdinand, MD Jay Skyler, MD
11:30am - 12:00pm	Genetics of Obesity	Jeffrey Friedman, MD
12:00pm – 1:45pm	Lunch Symposium A Optimizing the Role of GLP-1 Receptor Agonists in the T2DM Continuum of Care: Expert Recommendations and Interactive Clinical Scenarios Supported by an educational grant from Novo Nordisk, Inc.	Lawrence Blonde, MD Alan Garber, MD Jack Leahy, MD Julio Rosenstock, MD
12:00pm – 1:45pm	Lunch Symposium B Individualizing and Optimizing Antiplatelet Therapy in High-Risk Patient Groups: Moving Beyond a “One-Size-Fits-All” Approach Supported by an educational grant from Daiichi Sankyo, Inc. and Eli Lilly and Company	Eugene Braunwald, MD Christopher Cannon, MD Matthew Price, MD Steven Wiviott, MD
2:00pm – 2:30pm	Obesity Management: What is the Optimal Prescription for Diet and Exercise?	Robert Kushner, MD
2:30pm – 3:00pm	Pharmacotherapy for the Management of Obesity	Donna Ryan, MD
3:00pm – 3:30pm	Afternoon Break/Exhibit Hall
3:30pm – 4:00pm	Bariatric Surgery and Cardiometabolic Risk	D. Wayne Overby, MD
4:00pm – 4:30pm	Sleep Apnea, Obesity, and Cardiometabolic Risk	Atul Malhotra, MD
4:30pm – 5:15pm	Obesity Panel Discussion	moderator: Robert Eckel, MD panelists: Jeffrey Friedman, MD Robert Kushner, MD Atul Malhotra, MD D. Wayne Overby, MD Donna Ryan, MD
5:15pm	Closing Remarks	Robert Eckel, MD
5:15pm – 6:15pm	Welcome Reception
6:30pm – 8:30pm	Dinner Symposium Can We Control Diabetes and Cardiometabolic Risk Through Weight Loss? Examining the Clinical Implications of Obesity Therapies in Late-Stage Development Supported by an educational grant from Vivus, Inc.	Robert Eckel, MD Kishore Gadde, MD W. Timothy Garvey, MD Michelle Look, MD

Friday, October 22, 2010
6:30am – 8:00am	Breakfast Symposium Implementing High-Dose Insulin Therapy for Patients with T2DM and Severe Insulin Resistance in Clinical Practice: Expert Recommendations and Practical Considerations Supported by an educational grant from Lilly, USA, LLC	Wendy Lane, MD Anne Peters, MD Jay Skyler, MD
8:00am – 8:15am	Opening Remarks	Jay Skyler, MD
8:15am – 8:45am	Keynote Presentation The Key Elements of Glucose Metabolism	Richard Bergman, PhD
8:45am – 9:15am	Should We Use Pharmacotherapy in Prediabetes?	Harold Lebovitz, MD
9:15am –9:45am	Treatment of Type 2 Diabetes 2010	James Gavin III, MD
9:45am – 10:30am	Morning Break/Exhibit Hall
10:30am – 11:00am	Glycemic Control and Cardiovascular Disease	Jay Skyler, MD
11:00am – 11:20am	Pediatric CVD Prevention	Steven Lipshultz, MD
11:20am – 12:15pm	Diabetes Panel Discussion	moderator: Jay Skyler panelists: Richard Bergman, PhD James Gavin III, MD Harold Lebovitz, MD Steven Lipshultz, MD
12:15pm - 2:00pm	Lunch Symposium A Improving Endothelial Function with New-Generation Beta Blockers: Optimal Strategies for Controlling Hypertension and Reducing CV Risk Supported by an educational grant from Forest Laboratories, Inc.	George Bakris, MD Thomas Giles, MD R. Preston Mason, PhD
12:15pm – 2:00pm	Lunch Symposium B Advances in Statin Therapy: Expert Recommendations for Optimizing the Management of Dyslipidemia in the Clinically Complex Patient Supported by an educational grant from Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC	Christie Ballantyne, MD Eliot Brinton, MD Tara Dall, MD
2:15pm – 2:45pm	Hypertension in T2DM	George Bakris, MD
2:45pm – 3:15pm	CKD: A CHD Equivalent?	Peter McCullough, MD
3:15pm – 3:45pm	Afternoon Break/Exhibit Hall
3:45pm – 4:15pm	Vitamin D and Cardiometabolic Risk	Eric Rimm, ScD
4:15pm – 5:15pm	ACCF Case Study Session Convergence of Type 2 Diabetes and Cardiovascular Disease Sponsored by the American College of Cardiology Foundation Major support for this activity is provided through an educational grant from Takeda Pharmaceuticals, North America, Inc. Additional support is provided through an educational grant from sanofi-aventis US	moderator: Darren McGuire, MD panelists: George Bakris, MD Peter McCullough, MD
5:15pm	Closing Remarks	George Bakris, MD
6:00pm – 8:00pm	Dinner Symposia Diabetes, Dyslipidemia, and Hypertension: Identifying the Connections and Seizing the Opportunities for Global Cardiometabolic Risk Reduction Supported by an educational grant from Daiichi Sankyo, Inc.	George Bakris, MD Om Ganda, MD Ronald Goldberg, MD Suzanne Oparil, MD

Saturday, October 23, 2010
6:30am – 8:00am	Breakfast Symposia The Evolving Role of Endothelin Receptor Antagonists in PAH Management: Opportunities for Optimizing Patient Care and Outcomes Supported by an educational grant from Actelion Pharmaceuticals US, Inc.	David Badesch, MD Paul Forfia, MD Myung Park, MD
8:10am – 8:15am	Opening Remarks	Christie Ballantyne, MD
8:15am – 9:00am	Advances in the Clinical Management of HDL	Daniel Rader, MD
9:00am – 9:45am	Debate Niacin vs. Fibrates in Patients with Metabolic Syndrome	moderator: Christie Ballantyne, MD panelists: Henry Ginsberg, MD Allen Taylor, MD
9:45am – 10:15am	Morning Break
10:15am - 11:15am	Clinical Controversies in Lipid Management	moderator: Christie Ballantyne, MD panelists: Kathy Berra, MSN, ANP Deepak Bhatt, MD Tara Dall, MD Robert Eckel, MD
11:15am – 12:00pm	Hot Topics in Thrombosis and Diabetes	moderator: Deepak Bhatt, MD panelists: Richard Becker, MD Neal Kleiman, MD
12:00pm	Closing Remarks	Robert Eckel, MD
12:15pm – 2:00pm	Lunch Symposium

Dyslipidemia Conference • Hypertension Conference • Type 2 Diabetes Conference • Insulin Resistance Conference • Obesity Conference